TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

APEX MD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

APEX MD

ST13

US500000099345278

Class

5, 35, 44

Filing

99345278

Registration

8186121

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

07/24/2026

Classification

Registered

Trademark type

Word

Nice classes

5, 35, 44

Filing date

08/19/2025

Registration date

03/24/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2026

Last transaction

07/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2024-11-00

First use in commerce

2024-11-00

Drawing code

4

Owner type

16

Owner location

Orlando, FL, US

Examiner

RENNEKER, CHRISTOPHER JOHN

Current location

Historical data usage

Holders and representatives

Holders

Apex Health Holdings LLC

Representatives

Joshua M. Gerben Gerben Perrott, PLLC

Technical classification

Nice Classes

Class 5Class 35Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for weight management, weight loss and the maintenance of weight loss; Pharmaceutical preparations for testosterone replacement therapy, longevity peptides, and hormone replacement therapy

Class 35

On-line retail store services featuring pharmaceuticals for weight management, weight loss and the maintenance of weight loss; Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Subscription-based order fulfillment services in the field of pharmaceuticals for weight management, weight loss and the maintenance of weight loss; On-line retail store services featuring pharmaceuticals for testosterone replacement therapy, longevity peptides, and hormone replacement therapy; Subscription-based order fulfillment services in the field of pharmaceuticals for testosterone replacement therapy, longevity peptides, and hormone replacement therapy

Class 44

Medical care and pharmaceutical care consultation services; Nutrition consultation services for weight loss; Health care services, namely, wellness programs; Nutrition counseling; Providing medical advice in the field of weight management, weight loss and the maintenance of weight loss; Providing health information in the field of diet, nutrition, weight management, weight loss and the maintenance of weight loss; Weight management services, namely, providing weight loss and/or weight maintenance programs; Medical services, namely, telehealth services in the field of weight loss, weight management, prescription consultation, and nutritional counseling; Providing medical advice in the field of testosterone replacement therapy, preventative medicine, longevity peptides, and hormone replacement therapy; Providing health information in the field of testosterone replacement therapy, preventative medicine, longevity peptides, and hormone replacement therapy; all of the foregoing excluding business consulting services

Publications

History of USPTO decisions and trademark events.

20 publications found

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

07/24/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/13/2026

ES7R

TEAS SECTION 7 REQUEST RECEIVED

04/14/2026

CHPN

POST PUBLICATION AMENDMENT – NOT ENTERED

04/12/2026

APET

ASSIGNED TO PETITION STAFF

04/10/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2026

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

02/17/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/03/2026

PUBO

PUBLISHED FOR OPPOSITION

02/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/28/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/08/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

01/08/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/08/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

01/08/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/08/2026

DOCK

ASSIGNED TO EXAMINER

01/08/2026

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/07/2026

MAFR

APPLICATION FILING RECEIPT MAILED

08/19/2025

NWAP

NEW APPLICATION ENTERED

08/19/2025

Continuous trademark protection

Get notified about every new filing that threatens APEX MD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.